| [c-erbB-2 oncogene product expression in lacrimal gland tumors]. | None |
| Oligopeptide induction of a cytotoxic T lymphocyte response to HER-2/neu proto-oncogene in vitro. | None |
| c-erbB-2 oncogene expression in salivary gland tumours. | None |
| Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study. | None |
| Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. | None |
| Image analysis in quantitative PCR. An application for the measurement of c-erbB-2 oncogene amplification in DNA from human tumours. | None |
| In vitro and in vivo activity of a recombinant toxin, OLX-209, which targets the erbB-2 oncoprotein. | None |
| Co-expression of epidermal growth factor-receptor and c-erb B-2 proto-oncogene product in human salivary-gland adenocarcinoma cell line HSG and the implications for HSG cell autocrine growth. | None |
| Influence of a mutation in the transmembrane domain of the p185c-erbB2 oncogene-encoded protein studied by molecular dynamics simulations. | None |
| Triplex formation at the rat neu oncogene promoter. | None |
| Immunotoxins to the HER-2 oncogene product: functional and ultrastructural analysis of their cytotoxic activity. | None |
| c-erbB-2 oncoprotein expression and amplification in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: relationship to prognosis. | None |
| Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R. | None |
| Detection of the extracellular domain of c-erbB-2 oncoprotein in sera from patients with various carcinomas: correlation with tumor markers. | None |
| A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. | None |
| HER-2/neu oncogene: what does amplification mean?. | None |
| C-erbB-2 oncoprotein immunostaining in serous effusions. | None |
| Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. | None |
| The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage. | None |
| Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis. | None |